agilon health inc. (NYSE: AGL) stock fell -1.33% on Thursday to $20.00 against a previous-day closing price of $20.27. With 4.34 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.63 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $20.27 whereas the lowest price it dropped to was $19.04. The 52-week range on AGL shows that it touched its highest point at $29.44 and its lowest point at $15.00 during that stretch. It currently has a 1-year price target of $30.73.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AGL was down-trending over the past week, with a drop of -11.54%, but this was down by -18.53% over a month. Three-month performance dropped to -5.30% while six-month performance rose 23.92%. The stock gained 6.38% in the past year, while it has gained 23.92% so far this year. A look at the trailing 12-month EPS for AGL yields -0.23 with Next year EPS estimates of 0.11. For the next quarter, that number is -0.03. This implies an EPS growth rate of 75.90% for this year and 240.00% for next year.
Float and Shares Shorts:
At present, 413.14 million AGL shares are outstanding with a float of 406.88 million shares on hand for trading. On Apr 27, 2023, short shares totaled 36.78 million, which was 8.87% higher than short shares on Mar 30, 2023. In addition to Mr. Steven Jackson Sell as the firm’s Pres, CEO & Director, Mr. Timothy S. Bensley serves as its Chief Financial Officer.
Through their ownership of 106.14% of AGL’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 48.40% of AGL, in contrast to 48.37% held by mutual funds. Shares owned by individuals account for 13.04%. As the largest shareholder in AGL with 12.20% of the stake, Fidelity Management & Research Co holds 50,381,134 shares worth 50,381,134. A second-largest stockholder of AGL, Capital Research & Management Co, holds 42,435,971 shares, controlling over 10.27% of the firm’s shares. Morgan Stanley Investment Managem is the third largest shareholder in AGL, holding 35,891,111 shares or 8.69% stake. With a 3.51% stake in AGL, the American Funds New Economy Fund is the largest stakeholder. A total of 14,502,853 shares are owned by the mutual fund manager. The Vanguard Health Care Fund, which owns about 3.45% of AGL stock, is the second-largest Mutual Fund holder. It holds 14,265,479 shares valued at 346.22 million. American Funds Small Cap World Fu holds 3.17% of the stake in AGL, owning 13,114,300 shares worth 318.28 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, AGL reported revenue of $670.13M and operating income of -$21.05M. The EBITDA in the recently reported quarter was -$11.01M and diluted EPS was -$0.05.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AGL since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AGL analysts setting a high price target of $41.00 and a low target of $26.00, the average target price over the next 12 months is $31.54. Based on these targets, AGL could surge 105.0% to reach the target high and rise by 30.0% to reach the target low. Reaching the average price target will result in a growth of 57.7% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded AGL stock several times over the past three months with 29 Buys and 23 Sells. In these transactions, 726,910 shares were bought while 498,672 shares were sold. The number of buy transactions has increased to 88 while that of sell transactions has risen to 87 over the past year. The total number of shares bought during that period was 1,870,311 while 13,063,160 shares were sold.